![IJERPH | Free Full-Text | A Six-Year Gynecological Follow-Up of Immunosuppressed Women with a High-Risk Human Papillomavirus Infection IJERPH | Free Full-Text | A Six-Year Gynecological Follow-Up of Immunosuppressed Women with a High-Risk Human Papillomavirus Infection](https://www.mdpi.com/ijerph/ijerph-19-03531/article_deploy/html/images/ijerph-19-03531-sch001-550.jpg)
IJERPH | Free Full-Text | A Six-Year Gynecological Follow-Up of Immunosuppressed Women with a High-Risk Human Papillomavirus Infection
This figure describes management of histologic LSIL (CIN 1) preceded by... | Download Scientific Diagram
![Vaccines | Free Full-Text | Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study Vaccines | Free Full-Text | Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study](https://www.mdpi.com/vaccines/vaccines-10-00288/article_deploy/html/images/vaccines-10-00288-g001.png)
Vaccines | Free Full-Text | Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study
![Low-grade squamous intraepithelial lesion, cannot exclude high-grade:” TBS says “Don't Use It!” should I really stop it? - CytoJournal Low-grade squamous intraepithelial lesion, cannot exclude high-grade:” TBS says “Don't Use It!” should I really stop it? - CytoJournal](https://cytojournal.com/content/105/2017/14/1/img/CJ-14-13-g001.png)
Low-grade squamous intraepithelial lesion, cannot exclude high-grade:” TBS says “Don't Use It!” should I really stop it? - CytoJournal
![Predictive value of p16INK4a, Ki‑67 and ProExC immuno‑qualitative features in LSIL progression into HSIL Predictive value of p16INK4a, Ki‑67 and ProExC immuno‑qualitative features in LSIL progression into HSIL](https://www.spandidos-publications.com/article_images/etm/19/4/etm-19-04-2457-g00.jpg)
Predictive value of p16INK4a, Ki‑67 and ProExC immuno‑qualitative features in LSIL progression into HSIL
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
![Low-grade squamous intraepithelial lesion (LSIL/CIN 1). (b) Extensive... | Download Scientific Diagram Low-grade squamous intraepithelial lesion (LSIL/CIN 1). (b) Extensive... | Download Scientific Diagram](https://www.researchgate.net/publication/230894865/figure/fig1/AS:280404209750054@1443864981605/Low-grade-squamous-intraepithelial-lesion-LSIL-CIN-1-b-Extensive-L2-expression-in.png)
Low-grade squamous intraepithelial lesion (LSIL/CIN 1). (b) Extensive... | Download Scientific Diagram
![Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation - ScienceDirect Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0046817716300508-gr1.jpg)